Since 2014, UW Medicine’s Institute for Protein Design has spun off 10 startups, and the institute’s director, University of Washington biochemist David Baker, has co-founded 21 tech companies. After Baker… Read More
A team from the University of Washington led by Nobel laureate David Baker is using artificial intelligence to design effective enzymes from scratch — an accomplishment the researchers call “one… Read More
This week on the GeekWire Podcast, we sit down with some of the Seattle region’s “Uncommon Thinkers” — inventors, scientists, technologists and entrepreneurs transforming industries and driving positive change in… Read More
Editor’s note: This series profiles five of the Seattle region’s “Uncommon Thinkers”: inventors, scientists, technologists and entrepreneurs transforming industries and driving positive change in the world. They will be recognized Dec. 12… Read More
Three weeks after University of Washington biochemist David Baker won a Nobel Prize, the latest venture to spin out from his lab — Archon Biosciences — has emerged from stealth… Read More
University of Washington biochemist David Baker has won a share of this year’s Nobel Prize in chemistry for more than two decades of discoveries about the molecular structure of proteins… Read More
In a laboratory near downtown Seattle on the shores of Lake Union, Hetu Kamisetty is helping build what he says is the biotech company of the future. If talent, money… Read More
Outpace Bio, a Seattle startup using artificial intelligence to design proteins that are incorporated into cancer therapies targeting solid tumors, has raised $144 million in new cash from investors. The… Read More
Vilya, a biotech startup built off technology developed at the Seattle-based Institute for Protein Design, announced an expanded $71 million Series A investment round. The 2-year-old company, which has operations… Read More
A-Alpha Bio will receive $14.5 million from the Department of Defense (DOD) to expand a project with a national lab to help prepare for future biological threats using the company’s… Read More
The University of Washington’s Institute for Protein Design is on a hot streak. New studies, companies and spinouts are emerging at a rapid clip from the research hub, propelled by… Read More
The culture of collaboration in the Pacific Northwest, the impact of AI on biopharma, and the shape of new business models driven by AI were all topics at a panel… Read More
More than 100 researchers — including a Nobel laureate — have signed on to a call for the scientific community to follow a set of safety and security standards when… Read More
The Institute for Protein Design at the University of Washington is a startup factory, spinning out companies developing new protein-based therapeutics, industrial enzymes, materials, biosensors and more. A key to… Read More
The University of Washington this year expects to break ground on a new building that will anchor an ambitious, innovation-focused redevelopment called Portage Bay Crossing. The project will cover 69… Read More
— Hootsuite hired two new execs: Chief Revenue Officer Jessica Hartigan and Chief Customer Officer Ellen Terchila. Hartigan previously worked at the job-seeking platform CareerBuilder for more than a decade,… Read More
The Institute for Protein Design helped usher in an era for scientists to predict the structure of a protein using artificial intelligence tools, an accomplishment that helped it win the… Read More
Researchers at the University of Washington have discovered how to create peptide molecules that can slip through membranes to enter cells — and they’ve also created a company with $50… Read More
The news: Monod Bio raised $25 million to develop molecular biosensors that light up when they bind their target. The sensors can be designed to detect molecules linked to disease and… Read More
The Institute for Protein Design is an innovation factory. Since launching a decade ago, the University of Washington institution has grown to about 200 researchers and spun out eight startups… Read More
Prolific biotech co-founder and University of Washington scientist David Baker, head of the UW Institute for Protein Design, has launched a new company. Charm Therapeutics, based in London, harnesses deep… Read More
Here’s a rundown of the top life sciences and health news across the Pacific Northwest this week. Seagen CEO resigns after domestic violence arrest: Clay Siegall resigned as CEO and… Read More
The finalists for Health Innovation of the Year at the GeekWire Awards showcase the strength of science and discovery in the Pacific Northwest. Some have links to the region’s innovation… Read More
A study led by University of Washington researchers showcases a new way to generate potential drugs using computational design. The approach holds promise for accelerating the long, cumbersome and expensive… Read More
A new biotech startup has hatched from the University of Washington’s Institute for Protein Design with $6 million in funding and a leadership team fresh from Neoleukin Therapeutics, another IPD… Read More
New protein structures not seen in nature have emerged from deep learning software deployed by University of Washington researchers and their colleagues. The approach is a step toward building bespoke… Read More
A new study peers into the structure of hundreds of protein complexes in cells that control everything from energy use to DNA replication. Researchers at the University of Washington’s Institute… Read More
The lab of David Baker at the University of Washington’s Institute for Protein Design has released its application to solve one of the toughest problems in the life sciences: how… Read More
Seattle-based Icosavax has filed to go public via an IPO, just four years after it launched out of the University of Washington. The company, a spin-out from the UW’s Institute… Read More
Innovators across the Seattle area are tackling problems big and small with a variety of breakthroughs and technologies. Whether it’s improved battery performance, better vaccines, an easier way to purchase… Read More
